ROMLUSEVIMAB
UNII SM01RRU9KK

Substance Identification & Data

This profile provides standardized clinical and technical data for Romlusevimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SM01RRU9KK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2509447-08-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SM01RRU9KK

CAS Registry Number

2509447-08-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROMLUSEVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175226

National Cancer Institute reference terminology for clinical and research data.

INN ID

11992

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-256

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Romlusevimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROMLUSEVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN,RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONALANTIBODY

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) (SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-448) (VH (HOMO SAPIENS IGHV7-4-1*02 (96%)-(IGHD)-IGHJ6*01) (8.8.12) (1-119)-HOMO SAPIENS IGHG1*01 (CH2(M22>Y(254), S24>T(256), T26>E(258)), CH3(K107>DEL(449))) (120-448)) (222-213')-DISULFIDE WITH .LAMBDA.2 LIGHT CHAIN HOMO SAPIENS (1'-214') (V-LAMBDA (HOMO SAPIENS IGLV3-21*01 (98%)-IGLJ2*01)(6.3.11) (1'-108')-HOMO SAPIENS IGLC2*01 (109'-214')), DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHO-K1 CELL LINE, GLYCOFORM ALFA

ROMLUSEVIMAB [INN]

ROMLUSEVIMAB [USAN]

ROMLUSEVIMAB [WHO-DD]